Nang Kuang Pharmaceutical Co., Ltd.
1752
Rank in Stocks
#20072
Primarily based in Taiwan, Nang Kuang Pharmaceutical Co., Ltd. functions as a... Primarily based in Taiwan, Nang Kuang Pharmaceutical Co., Ltd. functions as a pharmaceutical enterprise. Its comprehensive product range includes various sterile injectable forms such as parenterals, aseptic parenterals, lyophilized injections, pre-filled syringes, and pre-mixed intravenous (IV) infusion bags. Additionally, it manufactures conventional dosage forms like tablets, capsules, oral suspensions, and topical applications. The company's offerings span a wide array of therapeutic categories, including treatments for cardiovascular, gastrointestinal, and nervous system disorders; alimentary and metabolic conditions; blood-related issues; antineoplastic and immunomodulatory agents; musculoskeletal and respiratory ailments; dermatological concerns; genito-urinary and sex hormone therapies; systemic hormones; and systemic antibacterials. Nang Kuang also supplies cosmetic products and comprehensive hospital solutions. Furthermore, Nang Kuang specializes in advanced pharmaceutical technologies, producing sterile and anticancer injectable products, controlled-release formulations (both injectable and oral), and oral disintegrating tablets. Founded in 1963, Nang Kuang Pharmaceutical Co., Ltd. is headquartered in Tainan City, Taiwan.
Share Price
$0.90691265
Last synced: 2026-11-10
Market Cap
$91.59M
Change (1 day)
-0.34%
Change (1 year)
-26.99%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Nang Kuang Pharmaceutical Co., Ltd. (1752)
Category
Healthcare
Operating Margin for Nang Kuang Pharmaceutical Co., Ltd. (1752)
Operating Margin as of November 2026 TTM: 12.39%
According to Nang Kuang Pharmaceutical Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 12.39%. At the end of 2025 the company had an operating margin of 13.67%.
Operating Margin history for Nang Kuang Pharmaceutical Co., Ltd. from 2009 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 12.39% | -9.36% |
| 2025 | 13.67% | -2.22% |
| 2024 | 13.98% | 15.63% |
| 2023 | 12.09% | -43.82% |
| 2022 | 21.52% | 63.90% |
| 2021 | 13.13% | 0.00% |
| 2020 | 13.13% | -9.64% |
| 2019 | 14.53% | 81.63% |
| 2018 | 8.00% | -45.76% |
| 2017 | 14.75% | -17.23% |
| 2016 | 17.82% | 14.75% |
| 2015 | 15.53% | 117.81% |
| 2014 | 7.13% | 357.05% |
| 2013 | 1.56% | -85.58% |
| 2012 | 10.82% | 172.54% |
| 2011 | 3.97% | -420.16% |
| 2010 | -1.24% | -143.06% |
| 2009 | 2.88% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 28.37% | -97.71% |
US
|
|
| 12.36% | -99.00% |
FR
|
|
| 9.83% | -99.21% |
US
|
|
| 31.11% | -97.49% |
JP
|
|
| 9.87% | -99.20% |
CH
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Nang Kuang Pharmaceutical Co., Ltd.'s operating margin
What is Nang Kuang Pharmaceutical Co., Ltd.'s operating margin?
Nang Kuang Pharmaceutical Co., Ltd.'s operating margin is 12.39%, as of Nov 2026.
What was Nang Kuang Pharmaceutical Co., Ltd.'s operating margin in 2025?
In 2025, Nang Kuang Pharmaceutical Co., Ltd.'s operating margin was 13.67%, compared with 13.98% in 2024.
How has Nang Kuang Pharmaceutical Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Nang Kuang Pharmaceutical Co., Ltd.'s operating margin was highest in 2022 (21.52%) and lowest in 2023 (12.09%).
How does Nang Kuang Pharmaceutical Co., Ltd.'s operating margin compare with similar companies?
Nang Kuang Pharmaceutical Co., Ltd.'s operating margin (12.39%) is higher than that of 3 of the 5 similar companies listed above. The highest among them is HOYA Corporation, with 31.11%.